Worldquant Millennium Advisors LLC bought a new position in shares of Exelon Co. (NASDAQ:EXC - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 102,944 shares of the company's stock, valued at approximately $4,174,000.
A number of other hedge funds have also modified their holdings of the business. Los Angeles Capital Management LLC boosted its stake in Exelon by 666.2% during the second quarter. Los Angeles Capital Management LLC now owns 3,583,477 shares of the company's stock worth $124,024,000 after buying an additional 3,115,763 shares during the last quarter. State Street Corp boosted its position in shares of Exelon by 3.7% during the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company's stock valued at $2,439,862,000 after acquiring an additional 2,156,259 shares during the last quarter. FMR LLC grew its holdings in shares of Exelon by 18.7% in the third quarter. FMR LLC now owns 11,782,549 shares of the company's stock valued at $477,782,000 after purchasing an additional 1,858,502 shares during the period. International Assets Investment Management LLC increased its position in Exelon by 4,103.5% during the third quarter. International Assets Investment Management LLC now owns 1,046,630 shares of the company's stock worth $42,441,000 after purchasing an additional 1,021,731 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its stake in Exelon by 101.8% during the third quarter. Robeco Institutional Asset Management B.V. now owns 1,344,978 shares of the company's stock worth $54,539,000 after purchasing an additional 678,490 shares during the period. 80.92% of the stock is currently owned by institutional investors and hedge funds.
Exelon Stock Down 0.3 %
Shares of NASDAQ EXC traded down $0.13 during midday trading on Friday, hitting $37.85. The company's stock had a trading volume of 6,946,415 shares, compared to its average volume of 5,366,195. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97. The firm has a market capitalization of $38.03 billion, a price-to-earnings ratio of 15.58, a price-to-earnings-growth ratio of 2.70 and a beta of 0.54. The business's fifty day simple moving average is $39.38 and its two-hundred day simple moving average is $37.86. Exelon Co. has a 1 year low of $33.35 and a 1 year high of $41.42.
Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.67 by $0.04. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The company had revenue of $6.15 billion during the quarter, compared to analysts' expectations of $5.85 billion. During the same quarter last year, the company posted $0.67 EPS. The firm's revenue was up 2.9% compared to the same quarter last year. On average, equities analysts predict that Exelon Co. will post 2.45 EPS for the current year.
Exelon Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Monday, November 11th will be given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 4.02%. The ex-dividend date of this dividend is Friday, November 8th. Exelon's dividend payout ratio is currently 62.55%.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the stock. Morgan Stanley dropped their price target on shares of Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a research note on Friday, November 22nd. UBS Group increased their price objective on Exelon from $40.00 to $43.00 and gave the stock a "neutral" rating in a research report on Friday, September 20th. Scotiabank lifted their target price on Exelon from $37.00 to $40.00 and gave the company a "sector perform" rating in a research report on Tuesday, August 20th. Jefferies Financial Group assumed coverage on Exelon in a research note on Thursday, September 19th. They issued a "buy" rating and a $46.00 price target on the stock. Finally, Barclays raised their price objective on Exelon from $41.00 to $44.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Eleven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $41.25.
Get Our Latest Research Report on EXC
Exelon Company Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
